
Brosmed
Stage
Series C | AliveMissing: Brosmed's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Brosmed's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Brosmed
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Brosmed is included in 2 Expert Collections, including Medical Devices.
Medical Devices
8,590 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health IT
7,901 items
Brosmed Patents
Brosmed has filed 1 patent.
The 3 most popular patent topics include:
- Angiology
- Continuum mechanics
- Elasticity (physics)

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
4/30/2020 | Solid mechanics, Elasticity (physics), Continuum mechanics, Vascular diseases, Angiology | Application |
Application Date | 4/30/2020 |
---|---|
Grant Date | |
Title | |
Related Topics | Solid mechanics, Elasticity (physics), Continuum mechanics, Vascular diseases, Angiology |
Status | Application |
Latest Brosmed News
Jul 28, 2020
Hillhouse’s GL VC Led Brosmed’s Series C to Long Chinese Medical Devices Hillhouse’s GL VC Led Brosmed’s Series C to Long Chinese Medical Devices Brosmed is the first medical device company that Hillhouse’s GL Ventures has ever invested since the inception this year. By Mengyao Zhang Updated 60 minutes ago Image credit: EqualOcean Guangdong Brosmed, a high-value medical device developer, announced the close of Series C of multi-hundreds millions. The investment is led by GL Ventures – the Beijing-based VC arm of Hillhouse Capital, participated by Cathay Capital and Innovative Development Guide Fund for Trade in Services. The deal was completed within four months. As the domestic brand in the coronary artery and peripheral balloon catheter provides a broad spectrum of products covering cardiovascular intervention, peripheral vascular intervention, neuro-intervention and accessory parts. It took fewer than five years for Brosmed to distribute products over 40 countries and regions. So far, the company is the only Chinese brand that provides high-end medical devices in the US, Japan and EU areas. Vascular intervention devices is an upsurge area that many medical giants have a close eye on, including Medtronic (MDT:NYSE), Johnson & Johnson (JNJ:NYSE), Danaher (DHR:NYSE) and Becton Dickinson (BDX:NYSE). As the mini-invasive interventional treatment has become a more popular therapy for cardiovascular diseases (CVD), the market for relevant devices is increasing. It is expected to see heavyweight players come to being soon.
Brosmed Frequently Asked Questions (FAQ)
Where is Brosmed's headquarters?
Brosmed's headquarters is located at 15th building, SMEs Venture Park, Dongguan.
What is Brosmed's latest funding round?
Brosmed's latest funding round is Series C.
Who are the investors of Brosmed?
Investors of Brosmed include Northern Light Venture Capital, Hillhouse Capital Management, Cathay Capital Private Equity, China Merchants Capital, bioVENTURE and 6 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.